Company Filing History:
1 out of 1 
1 out of 832,812 Years Active: 2004-2006
Title: Rosario Brancato: Innovator in Ocular Treatments
Introduction
Rosario Brancato is a notable inventor based in Florence, Italy. She has made significant contributions to the field of ophthalmology through her innovative research and patented inventions. With a total of 2 patents, her work focuses on the treatment and prevention of ocular diseases.
Latest Patents
One of her latest patents is titled "Use of quinone Q10 for the treatment of ocular diseases." This invention relates to the use of Coenzyme Q or functionally equivalent derivatives for the prevention, treatment, and attenuation of degenerative ocular pathologies. These pathologies can be hereditary, inflammatory, dysmetabolic, or age-related, and the degenerative process is often caused by apoptotic events due to hypoxia or other detrimental stimuli.
Another significant patent is "Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies." This invention utilizes ubiquinone Q10 in a collyrium pharmaceutical preparation for ocular topical administration. It aims to treat and prevent side effects on the eye following procedures such as photorefractive therapy (PRK) and laser-assisted in situ keratomileusis (LASIK), as well as exposure to solar light and ultraviolet radiation.
Career Highlights
Throughout her career, Rosario Brancato has worked with various companies, including Giuseppe Simonelli. Her innovative approach and dedication to research have positioned her as a key figure in the development of new treatments for ocular conditions.
Collaborations
Rosario has collaborated with notable individuals in her field, including Sergio Capaccioli and Nicola Schiavone. These partnerships have further enhanced her research and contributed to her success as an inventor.
Conclusion
Rosario Brancato's contributions to ocular treatments through her patented inventions demonstrate her commitment to advancing medical science. Her work continues to impact the field of ophthalmology positively.